Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Aug 25;13:935056. doi: 10.3389/fgene.2022.935056

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Zeng, Liu, He, Lu, Dai, Qi, Liu, Deng, Lu, Jin and Liu.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Immunotherapy response analysis between high- and low-risk groups. (A) Mutation profile of STAD patients in high- and low-risk groups. (B) Correlation analysis of TMB and risk scores. (C) Tumor mutation burden analysis between high- and low-risk groups. (D) Survival analysis between high- and low-tumor mutation burden (TMB) in STAD patients. (E) Survival analysis based on tumor mutation burden status and the risk score. (F) Microsatellite instability (MSI) analysis of STAD patients in high- and low-risk groups. (G) TIDE, dysfunction, and exclusion scores between high- and low-risk groups.